CY1107910T1 - Αντιγονα erysipelothrix rhusiopathiae και συνθεσεις εμβολιων - Google Patents

Αντιγονα erysipelothrix rhusiopathiae και συνθεσεις εμβολιων

Info

Publication number
CY1107910T1
CY1107910T1 CY20081100313T CY081100313T CY1107910T1 CY 1107910 T1 CY1107910 T1 CY 1107910T1 CY 20081100313 T CY20081100313 T CY 20081100313T CY 081100313 T CY081100313 T CY 081100313T CY 1107910 T1 CY1107910 T1 CY 1107910T1
Authority
CY
Cyprus
Prior art keywords
erysipelothrix rhusiopathiae
vaccine compositions
antigens
rhusiopathiae antigens
antigenic compositions
Prior art date
Application number
CY20081100313T
Other languages
English (en)
Inventor
David Stewart Roberts
Brian Thomas Suiter
Leroy Allen Swearingin
Original Assignee
Pfizer Products Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Incorporated filed Critical Pfizer Products Incorporated
Publication of CY1107910T1 publication Critical patent/CY1107910T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Η εφεύρεση αναφέρεται σε σταθεροποιημένες αντιγονικές συνθέσεις του Erysipelothrix rhusiopathiae και τυποποιήσεις εμβολίων που περιέχουν τέτοιες αντιγονικές συνθέσεις. Αντιγόνα της εφεύρεσης είναι αποτελεσματικά στην εξασφάλιση μακροχρόνιας προστασίας έναντι του ερυσίπελας σε ζώα.
CY20081100313T 1999-01-29 2008-03-20 Αντιγονα erysipelothrix rhusiopathiae και συνθεσεις εμβολιων CY1107910T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11770499P 1999-01-29 1999-01-29
EP99309202A EP1027895B1 (en) 1999-01-29 1999-11-18 Erysipelothrix rhusiopathiae antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
CY1107910T1 true CY1107910T1 (el) 2013-09-04

Family

ID=22374369

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100313T CY1107910T1 (el) 1999-01-29 2008-03-20 Αντιγονα erysipelothrix rhusiopathiae και συνθεσεις εμβολιων

Country Status (17)

Country Link
EP (1) EP1027895B1 (el)
JP (3) JP3535436B2 (el)
CN (1) CN1210062C (el)
AR (1) AR020022A1 (el)
AT (1) ATE386540T1 (el)
AU (1) AU776847B2 (el)
BR (1) BR9905853B1 (el)
CA (1) CA2290078C (el)
CY (1) CY1107910T1 (el)
DE (1) DE69938168T2 (el)
DK (1) DK1027895T3 (el)
ES (1) ES2301230T3 (el)
HK (1) HK1029062A1 (el)
NZ (1) NZ501128A (el)
PT (1) PT1027895E (el)
TW (1) TW546146B (el)
ZA (1) ZA997138B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CN107496913A (zh) * 2017-09-15 2017-12-22 天津瑞普生物技术股份有限公司 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法
CN107648599A (zh) * 2017-09-18 2018-02-02 天津瑞普生物技术股份有限公司 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法
CN110812473A (zh) * 2019-12-10 2020-02-21 广东君睿生物技术研究有限公司 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
ATE234916T1 (de) * 1991-11-15 2003-04-15 Pfizer Methode zur herstellung von gram-negativen bakteriellen vakzinen
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
JP3072345B1 (ja) * 1999-03-31 2000-07-31 農林水産省家畜衛生試験場長 豚丹毒菌の組換えサブユニットワクチン

Also Published As

Publication number Publication date
DE69938168D1 (de) 2008-04-03
AU776847B2 (en) 2004-09-23
JP3535436B2 (ja) 2004-06-07
PT1027895E (pt) 2008-03-18
CA2290078A1 (en) 2000-07-29
EP1027895A3 (en) 2001-07-18
ATE386540T1 (de) 2008-03-15
ZA997138B (en) 2001-05-16
JP2000219637A (ja) 2000-08-08
DK1027895T3 (da) 2008-06-09
JP2003160507A (ja) 2003-06-03
BR9905853A (pt) 2000-11-14
HK1029062A1 (en) 2001-03-23
CA2290078C (en) 2013-01-22
ES2301230T3 (es) 2008-06-16
CN1210062C (zh) 2005-07-13
BR9905853B1 (pt) 2011-11-01
EP1027895B1 (en) 2008-02-20
EP1027895A2 (en) 2000-08-16
NZ501128A (en) 2001-12-21
AU5944599A (en) 2000-08-03
JP2007119499A (ja) 2007-05-17
DE69938168T2 (de) 2009-02-26
TW546146B (en) 2003-08-11
AR020022A1 (es) 2002-03-27
JP4714167B2 (ja) 2011-06-29
CN1262129A (zh) 2000-08-09

Similar Documents

Publication Publication Date Title
BR9605153B1 (pt) vacina de combinação, e, kit de vacinação.
CY1121353T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
NO20023829D0 (no) Proteosom influensavaksine
DK1117440T3 (da) Farmaceutiske sammensætninger indeholdende paclitaxel
CY1117676T1 (el) Εμβολιο κατα του ιου του δυτικου νειλου
DK1459766T3 (da) Adjuvanssammensætninger til forstærkning af immunresponser på polynukleotidbaserede vacciner
CY1105896T1 (el) Χρησιμοποιηση ιδεβενονης δια την προστασια σκευασματων
CY1105010T1 (el) Πεπτιδια που λαμβανονται απο τη συνδεση (g) πρωτεϊνης του αναπνευστικου συνκυτιακου ιου
EP1242049A4 (en) HLA CLASS I A2 TUMOR ASSOCIATED ANTIGEN PEPTIDES AND VACCINES
CY1112658T1 (el) Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d
DK0588578T3 (da) Immunogener
CY1107485T1 (el) 3-θειομεθυλπυραζoλες ως παρασιτοκτoνα
CY1107910T1 (el) Αντιγονα erysipelothrix rhusiopathiae και συνθεσεις εμβολιων
DK0838222T3 (da) Vaccinesammensætninger, der omfatter inaktiverede immunogener og levende kyllingeanæmi-virus (CAV)
ATE364395T1 (de) Konjugat-impfstoffe zur vorbeugung der zahnkaries
CY1107322T1 (el) Συνδυασμενο εμβολιο κατα της hπατιτιδας α και ηπατιτιδας β
CY1109023T1 (el) Gm-αρνητικα μεταλλαγματα ehv
EP1136080A3 (en) Use of o-vanillin and o-vanillin/trolox combinations
ATE352315T1 (de) Neospora impstoff
BR9814958B1 (pt) Proteína de cimento de tecido, composição farmacêutica, uso da proteína de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido
IT1309584B1 (it) Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
ATE270112T1 (de) Streptococcus equi impfstoff
ATE505482T1 (de) Impfstoff gegen infektiöses lachsanämievirus
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen